The health and well-being of prostate cancer patients and male-to-female transsexuals on androgen deprivation therapy: A qualitative study with comments on expectations and estrogen

Psychology, Health and Medicine

Volumn 16, Issue 1, 2011, Pages 39-52

  Wassersug, Richard J ^a,b   Gray, Ross ^c  

^a DALHOUSIE UNIVERSITY   (Canada)

^b LA TROBE UNIVERSITY   (Australia)

^c UNIVERSITY OF TORONTO   (Canada)

Author keywords

health and illness experience; quality of life; sexual performance

Indexed keywords

ANTIANDROGEN; ESTRADIOL;

AGED; ARTICLE; DRUG EFFECT; EMOTION; HUMAN; LIBIDO; MALE; MIDDLE AGED; PROSTATE TUMOR; PSYCHOLOGICAL ASPECT; PSYCHOLOGY; QUALITY OF LIFE; SEXUAL BEHAVIOR; TRANSSEXUALISM;

AGED; ANDROGEN ANTAGONISTS; EMOTIONS; ESTRADIOL; HUMANS; LIBIDO; MALE; MIDDLE AGED; PROSTATIC NEOPLASMS; PSYCHOLOGY; QUALITY OF LIFE; SEXUAL BEHAVIOR; TRANSSEXUALISM;

EID: 78651335147     PISSN: 13548506     EISSN: None     Source Type: Journal    
DOI: 10.1080/13548506.2010.516364     Document Type: Article

References (61)

1. Alibhai, S.M.H., Gogov, S., & Allibhai, Z. (2006). Long-term side effects of androgen deprivation therapy in men with non-metastatic prostate cancer: A systematic literature review. Critical Reviews in Oncology/Hematology, 60(3), 201-215.
2. Asscheman, H., & Gooren, L.J.G. (1992). Hormone treatment in transsexuals. Journal of Psychology and Human Sexuality, 5(4), 39-54.
3. Beer, T.M., Bland, L.B., Bussiere, J.R., Neiss, M.B., Wersinger, E.M., Garzotto, M.,. .. Janowsky, J.S. (2006). Testosterone loss and estradiol administration modify memory in men. Journal of Urology, 175(1), 130-135.
4. Benner, P. (1994). The tradition and skill of interpretive phenomenology in studying health, illness, and caring practices. In P. Benner (Ed.), Interpretive phenomenology: Embodiment, caring, and ethics in health and illness (pp. 99-127). London: Sage.
5. Brett, M.A., Roberts, L.F., Johnson, T.W., & Wassersug, R.J. (2007). Eunuchs in contemporary society: Expectations, consequences, and adjustments to castration (part II). Journal of Sexual Medicine, 4(4i), 946-955.
6. Burns, S.M., & Mahalik, J.R. (2007). Understanding how masculine gender scripts may contribute to men's adjustment following treatment for prostate cancer. American Journal of Men's Health, 1(4), 250-261.
7. Chapple, A., & Ziebland, S. (2002). Prostate cancer: Embodied experience and perceptions of masculinity. Sociology of Health and Illness, 24(6), 820-841.
8. Cherrier, M.M., Aubin, S., & Higano, C.S. (2009). Cognitive and mood changes in men undergoing intermittent combined androgen blockade for non-metastatic prostate cancer. Psycho-Oncology, 18(3), 237-247. doi:10.1002/pon.1401
9. Courtenay, W.H. (2000). Constructions of masculinity and their influence on men's wellbeing:A theory of gender and health. Social Science & Medicine, 50(10), 1385-1401.
10. Dacal, K., Sereika, S.M., & Greenspan, S.L. (2006). Quality of life in prostate cancer patients taking androgen deprivation therapy. Journal of the American Geriatric Society, 54(1), 85-90.
11. Deurveilher, S., Rusak, B., & Semba, K. (2009). Estradiol and progesterone modulate spontaneous sleep patterns and recovery from sleep deprivation in ovariectomized rats. Sleep, 32(7), 865-877.
12. Donovan, K.A., & Jacobsen, P.B. (2007). Fatigue, depression, and insomnia: Evidence for a symptom cluster in cancer. Seminars in Oncology Nursing, 23(2), 127-135.
13. Elliott, S., Latini, D.M., Walker, L.M., Wassersug, R., Robinson, J.W., & ADT Survivorship Working Group (2010). Androgen deprivation therapy for prostate cancer: Recommendations to improve patient and partner quality of life. Journal of Sexual Medicine, 17(9), 2996-3010.
14. Engstrom, C.A. (2008). Hot flashes in prostate cancer: State of the science. American Journal of Men's Health, 2(2), 122-132.
15. Erikson, E.H., Erikson, J.M., & Kivnick, H. (1986). Vital involvement in old age. New York: W.W. Norton.
16. Fergus, K., Gray, R., & Fitch, M. (2002). Sexual dysfunction and the preservation of manhood: Experiences of men with prostate cancer. Journal of Health Psychology, 7(3), 303-316.
17. Fowler, F.J., Collins, M.M.N., Corkery, E.W., Elliott, D.B., & Barry, M.J. (2002). The impact of androgen deprivation on quality of life after radical prostatectomy for prostate carcinoma. Cancer, 95(2), 287-295.
18. Freedland, S.J., Eastham, J., & Shore, N. (2009). Androgen deprivation therapy and estrogen deficiency induced adverse effects in the treatment of prostate cancer. Prostate Cancer and Prostatic Diseases, 12(4), 333-338.
19. Gooren, L.J., Giltay, E.J., & Bunck, M.C. (2008). Long-term treatment of transsexuals with cross-sex hormones: Extensive personal experience. Journal of Clinical Endocrinology & Metabolism, 93(1), 19-25.
20. Gooren, L.J.G. (1999). Hormonal sex reassignment. International Journal of Transgenderism, 3(3), 1-7.
21. Gray, R.E., Wassersug, R.J., Sinding, C., Barbara, A.M., Trosztmer, C., & Fleshner, N. (2005). The experiences of men receiving androgen deprivation treatment for prostate cancer: A qualitative study. Canadian Journal of Urology, 12(4), 2755-2763.
22. Guise, T.A., Oefelein, M.G., Eastham, J.A., Cookson, M.S., Higano, C.S., & Smith, M.R. (2007). Estrogenic side effects of androgen deprivation therapy. Reviews in Urology, 9(4), 163-180.
23. Hagedoorn, M., Sanderman, R., Bolks, H.N., Tuinstra, J., & Coyne, J.C. (2008). Distress in couples coping with cancer: A meta-analysis and critical review of role and gender effects. Psychology Bulletin, 134(1), 1-30.
24. Hedlund, P.O. (2000). Side effects of endocrine treatment and their mechanisms: Castration, antiandrogens, and estrogens. The Prostate, 45(Suppl. 10), 32-37.
25. Herr, H.W., & O'Sullivan, M. (2000). Quality of life of asymptomatic men with nonmetastatic prostate cancer on androgen deprivation therapy. Journal of Urology, 163(6), 1743-1746.
26. Higano, C. (2006). Androgen deprivation therapy: Monitoring and managing the complications. Hematology/Oncology Clinics of North America, 20(4), 909-923.
27. Higano, C. (2003). Side effects of androgen deprivation therapy: Monitoring and minimizing toxicity. Urology, 61(Suppl. 2A), 32-38.
28. Isbarn, H., Boccon-Gibod, L., Carroll, P.R., Montorsi, F., Schulman, C., Smith, M.R.,. .. Studer, U.E. (2009). Androgen deprivation therapy for the treatment of prostate cancer: Consider both benefits and risks. European Urology, 55(1), 62-75.
29. Joly, F., Alibhai, S.M.H., Galica, J., Park, A., Yi, Q.L., Wagner, L., & Tannock, I.F. (2006). Impact of androgen deprivation therapy on physical and cognitive function, as well as quality of life of patients with nonmetastatic prostate cancer. Journal of Urology, 176(6), 2443-2447.
30. Kim, Y., Kashy, D.A., Wellisch, D.K., Spillers, R.L., Kaw, C.K., & Smith, T.G. (2008). Quality of life of couples dealing with cancer: Dyadic and individual adjustment among breast and prostate cancer survivors and their spousal caregivers. Annals of Behavioral Medicine, 35(2), 230-238.
31. Kornblith, A.B., Herr, H.W., Ofman, U.S., Scher, H.I., & Holland, J.C. (1994). Quality of life of patients with prostate cancer and their spouses: The value of a data base in clinical care. Cancer, 73(11), 2791-2802.
32. Maliski, S.L., Rivera, S., Connor, S., Lopez, G., & Litwin, M.S. (2008). Renegotiatingmasculine identity after prostate cancer treatment. Qualitative Health Research, 18(12),1609-1620.
33. Miller, J., Chan, B.K.S., & Nelson, H.D. (2002). Postmenopausal estrogen replacement and risk for venous thromboembolism: A systematic review and meta-analysis for the US Preventive Services Task Force. Annals of Internal Medicine, 136(9), 680-690.
34. Mohile, S.G., Mustian, K., Bylow, K., Hall, W., & Dale, W. (2009). Management of complications of androgen deprivation therapy in the older man. Critical Reviews in Oncology/Hematology, 70(3), 235-255.
35. Navon, L., & Morag, A. (2003a). Advanced prostate cancer patients' ways of coping with the hormonal therapy's effect on body, sexuality, and spousal ties. Qualitative Health Research, 13(10), 1378-1392.
36. Navon, L., & Morag, A. (2003b). Advanced prostate cancer patients' relationships with their spouses following hormonal therapy. European Journal of Oncology Nursing, 7(2), 73-80.
37. Navon, L., & Morag, A. (2004). Liminality as biographical disruption: Unclassifiability following hormonal therapy for advanced prostate cancer. Social Science & Medicine, 58(11), 2337-2347.
38. Nelson, C.J., Lee, J.S., Gamboa, M.C., & Roth, A.J. (2008). Cognitive effects of hormone therapy in men with prostate cancer. Cancer, 113(5), 1097-1106.
39. Norman, G., Dean, M.E., Langley, R.E., Hodges, Z.C., Ritchie, G., Parmar, M.K.,. .. Eastwood, A.G. (2008). Parenteral oestrogen in the treatment of prostate cancer: A systematic review. British Journal of Cancer, 98(4), 697-707.
40. Oliffe, J.L. (2006). Embodied masculinity and androgen deprivation therapy. Sociology of Health and Illness, 28(4), 410-432.
41. Paul, K.N., Dugovic, C., Turek, F.W., & Laposky, A.D. (2006). Diurnal sex differences in the sleep-wake cycle of mice are dependent on gonadal function. Sleep, 29(9), 1211-1223.
42. Paul, K.N., Laposky, A.D., & Turek, F.W. (2009). Reproductive hormone replacement alters sleep in mice. Neuroscience Letters, 463(3), 239-243.
43. Pirl, W.F., Greer, J.A., Goode, M., & Smith, M.R. (2008). Prospective study of depression and fatigue in men with advanced prostate cancer receiving hormone therapy. Psycho- Oncology, 17(2), 148-153.
44. Savard, J., Simard, S., Ivers, H., Hervouet, S., & Rioux, D. (2007). Depression and androgendeprivation therapy for advanced prostate cancer. Psycho-Oncology, 16(Suppl. 2), 151-152.
45. Shahinian, V.B., Kuo, Y.F., Freeman, J.L., & Goodwin, J.S. (2006). Determinants of androgen deprivation therapy use for prostate cancer: Role of the urologist. Journal of the National Cancer Institute, 98(12), 839-845.
46. Slabbekoorn, D., Van Goozen, S.H.M., Gooren, L.J.G., & Cohen-Kettenis, P.T. (2001). Effects of cross-sex hormone treatment on emotionality in transsexuals. The International Journal of Transgenderism, 5(3), 1-20.
47. Smith, M.R. (2007). Androgen deprivation therapy for prostate cancer: New concepts and concerns. Current Opinion in Endocrinology, Diabetes and Obesity, 14(3), 247-254.
48. Smith, M.R., Boyce, S.P., Moyneur, E., Duh, M.S., Raut, M.K., & Brandman, J. (2006). Risk of clinical fractures after gonadotropin-releasing hormone agonist therapy for prostate cancer. The Journal of Urology, 175(1), 136-139.
49. Soloway, C.T., Soloway, M.S., Kim, S.S., & Kava, B.R. (2005). Sexual, psychological and dyadic qualities of the prostate cancer 'couple'. British Journal of Urology International, 95(6), 780-785. doi: 10.1111/j.1464-410X.2005. 05400.x (Pubitemid 40547206)
50. Stryker, S., & Whittle, S. (2006). The transgender studies reader. New York: Routledge.
51. Traish, A.M., Guay, A., Feeley, R., & Saad, F. (2009). The dark side of testosterone deficiency: I. metabolic syndrome and erectile dysfunction. Journal of Andrology, 30(1),10-22.
52. Turner, V.W. (1967). The forest of symbols: Aspects of Ndembu ritual. New York: Cornell University Press.
53. Walker, L.M., & Robinson, J.W. (2010a). A description of heterosexual couples' adjustment to androgen deprivation therapy for prostate cancer. Pyscho-Oncology, July 11 [Epub ahead of print].
54. Walker, L.M., & Robinson, J.W. (2010b). The unique needs of couples experiencing androgen deprivation therapy for prostate cancer. Journal of Sex and Marital Therapy, 36(2), 154-165.
55. Wassersug, R.J. (2010). On the invisibility of the emasculated. Anthropology Today, 26(1), 1-3.
56. Wassersug, R.J., Gray, R.E., Barbara, A., Trosztmer, C., Raj, R., & Sinding, C. (2007). Experiences of transwomen with hormone therapy. Sexualities, 10(1), 101-122.
57. Wassersug, R.J., & Johnson, T.W. (2007). Modern-day eunuchs: Motivations for and consequences of contemporary castration. Perspectives in Biology and Medicine, 50(17951888), 544-556.
58. Wassersug, R.J. (2009). Passing through the wall: On outings, Exodus, angels, and the ark. Journal of Religion and Health, 48(3), 381-390.
59. Wassersug, R.J., & Oliffe, J.L. (2009). The social context for psychological distress fromiatrogenic gynecomastia with suggestions for its management. Journal of Sexual Medicine, 6(4), 989-1000.
60. Wibowo, E., Schellhammer, P., & Wassersug, R.J.. Estrogen's role in normal male function: Clinical implications for prostate cancer patients on androgen deprivation therapy. Journal of Urology, in press.
61. Wilson, M. (2002). "I am the prince of pain, for I am a princess in the brain": Liminal transgender identities, narratives and the elimination of ambiguities. Sexualities, 5(4), 425-448.